Ahjon81 Saturday, 11/21/20 05:39:12 PM Re: Fosco1 post# 2512 Post # of 2551 Very funny you actually act that you know about trials design. Venclexta was approved based on phase 1B non randomized trial, 114 patients enrolled. The overall survival was not even listed as secondary endpoint.